Search
ATI Basics: Fundamentals of Alternatives to Incarceration (ATI)
Call for Proposals: 2024 Police, Treatment, and Community Collaborative (PTACC) International Deflection and Pre-arrest Diversion Summit
Proposals are now being accepted for the 2024 Police, Treatment, and Community Collaborative (PTACC) International Deflection and Pre-arrest Diversion Summit. All submissions must be uploaded by April 19, 2024 at 12:00 PM PDT in order to be...
Residential addiction treatment for adolescents is scarce and expensive
2022 NSDUH Annual National Report
Description:
Read key findings from the 2022 National Survey on Drug Use and Health (NSDUH). This report highlights 2022 statistics on substance use, mental health, and treatment in the United States. These national indicators are...
Science of Self-Care: How It Helps and Why It Matters
Recovery: The Many Paths to Wellness (Chapter 5 from Facing Addiction in America)
The Many Paths to Wellness: Explore Chapter 5 in "Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health," which defines the concept of recovery from substance use disorders and reviews methods used by...
Alarming Statistics: Over One Million Young Drivers Imperil Lives with Marijuana and Alcohol Behind the Wheel
Driving under the influence (DUI) of psychoactive substances is an issue of paramount concern in both public health and the criminal justice system. It affects millions of Americans yearly, and while there is extensive research on DUI among...
Substance Use Disorders (SUD) and Type 2 Diabetes: Integration of Evidence-Based Diabetes Care to Promote Quality Health Outcomes
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 24, 2023
Today, the U.S. Food and Drug Administration (FDA) approved the extended-release Brixadi (buprenorphine) subcutaneous (for use under the skin) injection to treat moderate to severe opioid use disorder...
PTACC Annual Deflection Summit Call for International Presenters
Proposals are now being accepted for the 2023 Police, Treatment, and Community Collaborative’s (PTACC) National Deflection and Pre-arrest Diversion Summit.
All submissions must be uploaded by May 5, 2023 at 2:00 EDT in order to be...
Outpatient Alcohol Withdrawal Management: A Tool for Global Practice Settings
Resilience in Leadership: Key Behaviors for Self-Care and Caring for Others
A Practical DBT Workbook for Radically Eliminating Neurodivergent Disorders: How to Help You Confront Your Social Anxiety Triggers and Improve Your Interpersonal Effectiveness and Social Skills
- The 4 core skills of dialectical behavior therapy, and how they can benefit people with neurodivergent conditions (ADHD, Autistic, Dyslexia ,Dyspraxia and Tourette Syndrome etc.. because they have high probability of developing addictions...
Prevention and Treatment of HIV Among People Living with Substance Use and/or Mental Disorders
Focus of this guide
People with mental illness and/or SUD are disproportionally affected by HIV. They may participate in behaviours that increase risk for contracting and transmitting HIV, such as sharing injection drug equipment or...
ICUDDR November 2022 Newsletter
We are pleased to present our November 2022 newsletter, please enjoy the articles and share at your leisure. Thank you!
Community Engagement: An Essential Component of an Effective and Equitable Substance Use Prevention System
Community engagement is often cited as a tool to improve the health of the community and its members. This guide will review evidence related to leveraging community engagement to support the implementation and scale-up of evidence-based...
The Substance Use Professional’s Guide to Addressing Medical Cannabis in Substance Use Treatment Settings
New Training for Medical Providers: Integrating Addiction Medicine With Treatment Courts
NADCP is partnering with the American Society of Addiction Medicine (ASAM) to offer a new training for medical providers working with participants in drug treatment courts. This training will help medical providers learn how to successfully...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member